UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 進行前立腺癌における骨転移：マネージメントbone metastases in advanced prostate cancer management [show details]
…metastatic castration-resistant prostate cancer (CRPC) such as abiraterone/prednisone, enzalutamide, Radium-233 (Ra-223), docetaxel, cabazitaxel, and mitoxantrone have all been shown to reduce SREs and improve …
- 2. 去勢抵抗性前立腺癌（CRPC）の治療法の概要overview of the treatment of castration resistant prostate cancer crpc [show details]
…progressed on or are not candidates for taxane chemotherapy. Radium-223 (Ra-223) is an alpha-particle-emitting radiopharmaceutical. Radium is a bone-seeking element, and its radioactive decay allows for …
- 3. 有痛性骨転移のマネージメントのための放射線療法radiation therapy for the management of painful bone metastases [show details]
…breast cancer. Clinical trials are underway examining the efficacy of radium-223 in a variety of solid tumor types. Radium-223 dichloride is an alpha-particle-emitting radiotherapeutic drug that mimics calcium …
- 4. がん治療における放射線治療手技radiation therapy techniques in cancer treatment [show details]
…treatment of bone metastases. In particular, radium-223 emits alpha particles, which release their energy over a very short distance, thus sparing other organs. Radium-223 has been developed as an important alternative…
- 5. 放射線関連肉腫radiation associated sarcomas [show details]
…(RT) for benign bone conditions were published in 1922, and a report of bone sarcomas in the jaws of radium-dial painters followed in 1929 . Sarcomas are rare malignant tumors that arise from mesenchymal tissues…
Related Links
- ... 、ファザジニウム、ガラミン、ヘキサカルバコリン、ヘキサフルオレニウム、ラウデキシウム、レプトダクチリン、メトクリン、およびツボクラリンの塩が含まれる。これらのそれぞれの筋弛緩化合物は第四級アンモニウムカチオン基 ...
- ... 、ラキニモド、ラサロシド、ラシナビル、ラソフォキシフェン、ラタノプロスト、ラウデキシウム、ラウルセチウム、ラウロカプラム、ラウログアジン、ラウロリニウム、ラウリルイソキノリニウム、ラボルチジン、ラザベミド、レシミ ...